Delivery Order SPE2DR25D2203-SPE2DR26FD2UA
- Not listed
- On August 14, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,496.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens. This non-competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injections valued at $1,801.80. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- On July 25, 2025, the Defense Logistics Agency awarded a delivery order valued at $12,103.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml units). The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a...
- On November 6, 2025, the Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $1,116.83. This firm fixed-price delivery order, which has an ultimate completion date of November 7, 2025, was competitively awarded with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $2,026.98. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trulicity 3 mg/0.5 mL pen injectors valued at $5,858.53 with a firm fixed price structure. The award was made competitively with no set-aside designation and is scheduled for completion by December 9, 2025. Performance will take place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $4,041.39 with a completion date of September 2, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $2,396.43 under a firm fixed price contract. This non-set-aside delivery order, with an ultimate completion date of May 6, 2025, is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $15,344.90. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors with a ceiling value of $1,955.22. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract utilized no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract...
- SPE2DR25D2203Indefinite Delivery Contract
- SPE2DR25D2203-SPE2DR26FD2UADelivery Order
On January 6, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,215.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injections. The award is a firm fixed-price contract with an ultimate completion date of January 7, 2026, and represents a non-set-aside, competitively awarded procurement. The contractor's place of performance is located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that supplies an extensive range of medical products to federal agencies. The company's demonstrated capability to fulfill federal procurement requirements through open competition is evidenced by its consistent delivery of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This particular award for Trulicity, a diabetes medication, reflects the company's role as a critical vendor supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/5/26 |